Gossamer Bio (GOSS) Non-Current Assets (2018 - 2026)

Gossamer Bio has reported Non-Current Assets for 9 years, with the latest figure at $4.1 million in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 17.6% year-over-year to $4.1 million in Q2 2026; TTM through Jun 2026 was $17.9 million, a 19.02% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, down 14.79% from the prior year.
• Non-Current Assets was $4.1 million for Q2 2026 at Gossamer Bio, down from $4.4 million in the prior quarter.
• The five-year high for Non-Current Assets was $13.9 million in Q1 2022, with the low at $2.5 million in Q2 2024.
• Average Non-Current Assets over 5 years is $7.0 million, with a median of $5.4 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets plunged 69.59% in 2024, then surged 97.52% in 2025.
• Over 5 years, Non-Current Assets stood at $10.6 million in 2022, then slumped by 48.94% to $5.4 million in 2023, then rose by 0.13% to $5.4 million in 2024, then dropped by 14.79% to $4.6 million in 2025, then dropped by 10.05% to $4.1 million in 2026.
• The last three Non-Current Assets figures came in at $4.1 million (Q2 2026), $4.4 million (Q1 2026), and $4.6 million (Q4 2025), per Business Quant data.